Kasumi-1 In Vitro Telomere Length Analysis Assay (Senescence)

CAT#: ITS-1122-YF3931
Target Cell Organism: Human
Target Cell Name: Kasumi-1
Assay Type: Cellular Senescence in Cancer Assays
Assay Overview
This assay is to provide Kasumi-1-based In Vitro Telomere Length Analysis Assay (Senescence) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
Kasumi-1
Target Cell Organism
Human
Target Cell Background
Kasumi-1 is a myeloblast cell that was isolated from the peripheral blood of an acute myeloblastic leukemia Asian male patient. This cell line was deposited by H Asou in 1989.
Related Diseases
Acute Myeloblastic Leukemia; AML
Research Area
Oncology
Assay Name
In Vitro Telomere Length Analysis Assay (Senescence)
Short Description
Kasumi-1-cell based In Vitro Telomere Length Analysis Assay (Senescence)
Assay Description
For the analysis of telomere length, terminal restriction fragment anal ysis technique has been the commonly used technique for a long time.
Assay Type
Cellular Senescence in Cancer Assays
Assay Type Details
Cell senescence is described as an irreversible physiological event of cell growth arrest, which is known to be caused by alterations of telomeres, oxidative stress, DNA damage and some oncogenes. Inhibition of the program of senescence is one of the main features of tumor cells and it has been reported that cancer cells can be induced to undergo senescence by chemo- and radiotherapies and genetic alterations. Telomeres help to prevent uncontrolled cell proliferation and the absence of telomeres results in aneuploidy and cell death.
Assay Subtype
Telomere Length Analysis Assay
For Research Use Only | Not For Clinical Use
Online Inquiry